On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
ThursdayJan 21, 2021 11:36 am

Josemaria Resources Inc. (TSX: JOSE) (OTC: JOSMF) Rapidly Developing New Copper-Gold Project in Argentina as Copper Demand Projected to Rise

Industry report suggests demand for copper will increase nine-fold due in part to increased production of Electric Vehicles S&P analysts predict copper shortages in coming years Josemaria is one of world’s few readily developable copper-gold projects Recent feasibility study concluded that Josemaria is robust, low-risk project with significant yield potential As one industry report suggests that the increased production of electric vehicles (“EVs”) will send copper demand up nine-fold (https://ibn.fm/6dyXW), S&P analysts predict a looming copper deficit in the coming years (https://ibn.fm/0i7iV). While market forces continue to exert upward pressure on the price of copper, Josemaria Resources (TSX: JOSE) (OTCQB: JOSMF), a…

Continue Reading

ThursdayJan 21, 2021 11:00 am

QualityStocksNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Beginning of MS1819 Extension Study with Initial Dosing of Two Patients

AzurRx BioPharma (NASDAQ: AZRX), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (“GI”) diseases, has begun its Phase 2b OPTION 2 extension study of MS1819. AZRX announced that the first two patients have been dosed in the extension study of MS1819, which uses immediate release capsules for the treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis. MS1819 is a recombinant lipase enzyme for the treatment of exocrine pancreatic insufficiency associated with cystic fibrosis and chronic pancreatitis. The OPTION 2 extension phase design, which was recently announced by AzurRx, is designed to evaluate patients…

Continue Reading

ThursdayJan 21, 2021 10:27 am

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Slated to Present Trailblazing Gene Therapies at the MoneyShow Accredited Investors Virtual Expo

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, this morning announced that the company’s President and Chief Executive Officer, Rodney Varner, will provide a company overview at the MoneyShow Accredited Investors Virtual Expo taking place virtually January 26-28, 2021. GNPX’s presentation will shine a light on recent advancements concerning its upcoming clinical trials for the treatment of non-small cell lung cancer. The company will present at 12:25 PM EST on Thursday, January 28th. The presentation will be available for replay on the company’s website and www.MoneyShow.com. To register for the…

Continue Reading

ThursdayJan 21, 2021 10:21 am

QualityStocksNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) Enters Doctor Practitioner Space with Large-Scale Distribution Agreement

HempFusion Wellness Inc. (TSX: CBD.U), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, has entered into a large-scale distribution agreement with Fullscript.com to launch a doctor practitioner sales channel. Fullscript is a leading eCommerce platform designed to allow health professionals to dispense professional-grade natural health products. Based on the agreement, HempFusion’s seven Biome Research SKUs will be available from Fullscript distribution centers, effective Feb. 2, 2021. The agreement is a significant step in HempFusion’s strategy to enter into the doctor practitioner sales space. Fullscript has become one of the largest distributors in the doctor…

Continue Reading

ThursdayJan 21, 2021 10:12 am

QualityStocksNewsBreaks – Plus Products Inc.’s (CSE: PLUS) (OTCQX: PLPRF) Sour Watermelon UPLIFT Gummies Recognized as LeafLink’s Best-Selling California Edible for 2020

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a cannabis and hemp-branded products company in the United States, today announced that LeafLink, a platform that connects 1,700+ cannabis brands with over 5,600 licensed retailers, recognized PLPRF’s Sour Watermelon UPLIFT gummies as the best-selling cannabis edible in the California market. The gummies also secured a spot in the top five best-selling edible products across all active markets. “PLUS is thrilled to see one of our products receive such noteworthy recognition,” PLUS Co-founder and CEO Jake Heimark stated in the news release. “We have built the company around providing the California market with the…

Continue Reading

ThursdayJan 21, 2021 9:59 am

QualityStocksNewsBreaks – ev Transportation Services Inc. CEO Discusses Upcoming Initiatives for 2021 in NNW Audio Interview

ev Transportation Services (“evTS”), an electric vehicle (“EV”) manufacturer focused on the essential services and urban mobility markets, this morning announced that the company’s founder and chief executive officer, David Solomont, was featured in an exclusive audio interview with NetworkNewsWire (“NNW”). Among other highlights, Solomont summarized the company’s outlook for 2021 as well as his viewpoint regarding the future of EVs. “Dealers are incredibly important, because they’re the ones who have the tightest relationships with customers and prospects. By the end of the first quarter, we want to expand our dealer network from four dealers to eight, all carefully chosen,”…

Continue Reading

ThursdayJan 21, 2021 9:32 am

QualityStocksNewsBreaks – Net Element (NASDAQ: NETE) Brings Former Tesla Lead on Board as VP of EV Manufacturing

Net Element (NASDAQ: NETE), a financial technology company in the process of becoming a pure-play electric vehicle (“EV”) manufacturer through a pending definitive agreement with privately held Mullen Technologies Inc., has announced the hiring of John Taylor as vice president of manufacturing for Mullen Automotive. Taylor comes from Tesla, where he oversaw more than 12 major vehicle launches, including Tesla’s highly successful Model S; Taylor also has impressive experience in plant start-ups. Taylor’s deep engineering experience is invaluable as, in his new role, he will  oversee Mullen's manufacturing facilities for the MX-05 and MX-07 SUVs. Taylor earned a degree from the Philpot School…

Continue Reading

WednesdayJan 20, 2021 3:09 pm

QualityStocksNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Announces Upcoming Shareholder Meeting

Green Hygienics (OTCQB: GRYN), an innovative, technology-driven enterprise, has announced an upcoming shareholder call. The purpose of the call is to update shareholders on the company’s achievements in 2020; the call will also include an overview of current initiatives and projects, sales information, and GRYN’s future road map. The event is scheduled for Thursday, Jan. 28, 2021, and will begin at 1 p.m. Pacific Standard Time/4 p.m. Eastern Time. Green Hygienics CEO Ron Loudoun will host the call, along with COO Kyle MacKinnon. In addition, company representatives will answer questions following the presentation; potential questions can be submitted to [email protected]

Continue Reading

WednesdayJan 20, 2021 2:50 pm

QualityStocksNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Appoints C.A. Fortune E-Comm to Represent Entire Alkaline88 Non-CBD Beverage Line

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER) has announced a partnership with C.A. Fortune E-Comm, the online arm of C.A. Fortune, to offer WTER’s A88 family of beverages across various e-commerce platforms. The partnership is effective Jan. 21, 2021, and platforms include Amazon.com, Walmart.com, Kroger.com, Thrive.com, Boxed.com and zulilly.com among others. WTER is a producer of premium bottled alkaline water, flavor-infused waters, and CBD-infused products sold under the brand names Alkaline88(r), A88 Infused(TM), and A88CBD(TM) respectively. In the announcement, WTER noted that the C.A. E-Comm team includes account representatives, inventory specialists, content specialists and data analysts. These experts will assist…

Continue Reading

WednesdayJan 20, 2021 2:13 pm

Cybin Inc. (NEO: CYBN) Announces Partnership with Neurotech Pioneer to Leverage Innovative Technology for Psychedelic Therapeutics

CYBN partners with pioneer company focused on exploring, quantifying the human mind Innovative Flow technology adds exciting dimension to Cybin’s commitment to develop breakthrough treatments for mental health disorders Innovative technology opens new frontier in psychedelic therapeutics Cybin (NEO: CYBN), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, is partnering with neurotech pioneer HI, LLC dba Kernel to quantify brain activity in real time during psychedelic experiences (https://ibn.fm/3AG5G). CYBN plans to do this by leveraging Kernel Flow, Kernel’s breakthrough technology, for its upcoming clinical work. “Access to Kernel’s innovative Flow technology adds another exciting dimension to…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered